• RA Capital Management, a 10% owner of Vor Biopharma, reported acquiring 2.1 million common shares on July 16, 2026 at USD 0.002 each.
• The filing also showed a disposition of 213 common shares at USD 19.75.
• RA Capital reported 4,501,882 common shares beneficially owned following the transactions.
• It also reported 7,900,000 pre-funded warrants outstanding, exercisable at USD 0.002, priced at USD 5.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000776), on July 21, 2026, and is solely responsible for the information contained therein.